Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI105861

The contribution of thyroxine-binding prealbumin to the binding of thyroxine in human serum, as assessed by immunoadsorption

Kenneth A. Woeber and Sidney H. Ingbar

1Thorndike Memorial Laboratory and the Second and Fourth (Harvard) Medical Services, Boston City Hospital and the Department of Medicine, Harvard Medical School, Boston, Massachusetts 02118

Find articles by Woeber, K. in: PubMed | Google Scholar

1Thorndike Memorial Laboratory and the Second and Fourth (Harvard) Medical Services, Boston City Hospital and the Department of Medicine, Harvard Medical School, Boston, Massachusetts 02118

Find articles by Ingbar, S. in: PubMed | Google Scholar

Published July 1, 1968 - More info

Published in Volume 47, Issue 7 on July 1, 1968
J Clin Invest. 1968;47(7):1710–1721. https://doi.org/10.1172/JCI105861.
© 1968 The American Society for Clinical Investigation
Published July 1, 1968 - Version history
View PDF
Abstract

An immunoadsorption technique employing a rabbit antiserum specific for human serum prealbumin has been devised to remove thyroxine (T4)-binding prealbumin (TBPA) from serum completely without affecting the T4-binding activity of thyroxine-binding globulin (TBG) or the concentration of the other major proteins in serum. As judged from the proportion of T4 associated with the antigen-antibody precipitate, only about 15% of the endogenous T4 is bound by TBPA, a value considerably less than that indicated by electrophoretic methods. As judged from the increase in the proportion of free T4 that followed immunoadsorption of TBPA, TBPA does act as one determinant of the proportion of free T4 but is far less important than TBG in this respect. A decrease in the T4-binding capacity of TBPA cannot solely account for the increase in the proportion of free T4 in the sera of ill patients, since a comparable increase does not occur in normal sera after complete removal of TBPA. From data obtained in normal and abnormal sera before and after immunoadsorption of TBPA, estimates of the equilibrium constants for the interactions between T4 and its binding proteins, as they exist in serum, have been derived. The values obtained were: KALB, 6.2 × 105; KTBPA, 2.3 × 108; and KTBG, 1.7 × 1010.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1710
page 1710
icon of scanned page 1711
page 1711
icon of scanned page 1712
page 1712
icon of scanned page 1713
page 1713
icon of scanned page 1714
page 1714
icon of scanned page 1715
page 1715
icon of scanned page 1716
page 1716
icon of scanned page 1717
page 1717
icon of scanned page 1718
page 1718
icon of scanned page 1719
page 1719
icon of scanned page 1720
page 1720
icon of scanned page 1721
page 1721
Version history
  • Version 1 (July 1, 1968): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts